Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,601 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regulatory T cells and autoimmunity.
Vila J, Isaacs JD, Anderson AE. Vila J, et al. Curr Opin Hematol. 2009 Jul;16(4):274-9. doi: 10.1097/MOH.0b013e32832a9a01. Curr Opin Hematol. 2009. PMID: 19417650 Review.
BSR and BHPR guideline for the treatment of systemic sclerosis.
Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, Fligelstone K, Gompels LL, Griffiths B, Herrick AL, Pang J, Parker L, Redmond A, van Laar J, Warburton L, Ong VH; BSR and BHPR Standards, Guidelines and Audit Working Group. Denton CP, et al. Among authors: vila j. Rheumatology (Oxford). 2016 Oct;55(10):1906-10. doi: 10.1093/rheumatology/kew224. Epub 2016 Jun 9. Rheumatology (Oxford). 2016. PMID: 27284161 Free article. Review. No abstract available.
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus.
Ingegnoli F, Herrick AL, Schioppo T, Bartoli F, Ughi N, Pauling JD, Sulli A, Cutolo M, Smith V; European League against Rheumatism (EULAR) study group on microcirculation in rheumatic diseases and the Scleroderma Clinical Trials Consortium. Ingegnoli F, et al. Rheumatology (Oxford). 2021 Mar 2;60(3):1410-1418. doi: 10.1093/rheumatology/keaa457. Rheumatology (Oxford). 2021. PMID: 32984894
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
In vitro potentiation of tetracyclines in Pseudomonas aeruginosa by RW01, a new cyclic peptide.
Roson-Calero N, Gomis Font MA, Ruiz-Soriano A, Just-Baringo X, Pachón-Ibáñez ME, Salvador JP, Marco MP, Giralt E, Oliver A, Ballesté-Delpierre C, Vila J. Roson-Calero N, et al. Among authors: vila j. Antimicrob Agents Chemother. 2024 Dec 23:e0145924. doi: 10.1128/aac.01459-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39714156 Free article.
1,601 results